bpc-157 third party tested Research Peptide — UNYX PeptidesUNYX Peptides BPC-157 | 5mg & 10mg

Heresco-Levy, U., Javitt, D

In occlusion/occlusion-like syndromes affecting both periphery and brain (portal hypertension, caval hypertension, intracranial hypertension), BPC-157 simultaneously normalized blood pressure disturbances, healed gastrointestinal and liver lesions, minimized brain lesions and hemorrhage, prevented thrombosis, and preserved neurological function

ATP fuels every single function in our bodies

Even the small folate cycle can only proceed to a limited extent because the supply of THF from the large folate cycle is no longer given

Research Applications Obesity and weight management research Fat metabolism and lipolysis studies Body composition research Metabolic disorder studies Diabetes and insulin resistance research Cardiovascular risk factor studies Safety Profile AOD9604 has shown good safety and tolerability in clinical trials